Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a pioneering entity in the medical technology industry, is headquartered in the United States. Founded in 2007, the company has made significant strides in the treatment of obstructive sleep apnoea (OSA) through its innovative Inspire therapy. This unique, implantable device offers a groundbreaking alternative to traditional CPAP machines, providing patients with a more comfortable and effective solution for managing their condition. With a focus on enhancing patient quality of life, Inspire Medical Systems has established a strong market position, recognised for its commitment to advancing sleep health. The company operates primarily in North America and has garnered notable achievements, including FDA approval for its flagship product. By combining cutting-edge technology with a patient-centric approach, Inspire Medical Systems continues to lead the way in transforming sleep disorder treatment.
DitchCarbon Score
How does Inspire Medical Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inspire Medical Systems, Inc.'s score of 37 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Inspire Medical Systems, Inc.'s reported carbon emissions
In 2023, Inspire Medical Systems, Inc. reported total carbon emissions of approximately 56,219,020 kg CO2e. This figure includes Scope 1 emissions of about 50,630 kg CO2e, Scope 2 emissions of approximately 401,740 kg CO2e, and a significant contribution from Scope 3 emissions, which total around 55,766,650 kg CO2e. The Scope 3 emissions breakdown reveals major sources, including purchased goods and services (approximately 41,471,850 kg CO2e) and business travel (about 6,602,150 kg CO2e). Inspire Medical Systems is actively working towards climate risk assessment and scenario analysis, initiated in early 2025, to better understand and manage both physical and transition risks associated with climate change. This assessment aims to inform their strategies for reducing emissions in both Scope 1 and Scope 2 by 2025, although specific reduction targets have not been disclosed. The company does not inherit emissions data from any parent organisation, ensuring that their reported figures are solely reflective of their own operations. As part of their commitment to sustainability, Inspire Medical Systems is focused on enhancing their climate strategies and disclosures in line with evolving requirements.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 50,630 |
| Scope 2 | 401,740 |
| Scope 3 | 55,766,650 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inspire Medical Systems, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
